Steven A. Rosenberg, MD, PhD, FAACR
Pezcoller Foundation-AACR International Award for Extraordinary Achievement in Cancer Research

Steven A. Rosenberg, MD, PhD, FAACR

Chief, Surgery Branch, Senior Investigator, Head, Tumor Immunology Section
National Cancer Institute
Bethesda, Maryland

For pioneering the development of effective immunotherapies and gene therapies for patients with advanced cancers and being the first to introduce a foreign gene into a human and to successfully utilize T-cell receptors against solid epithelial cancers and chimeric antigen receptors against lymphomas. He has identified somatic mutations as targets of T-cell immunotherapy and has demonstrated that administration of tumor infiltrating lymphocytes along with a  IL-2 and a lymphodepleting preparative regimen stimulates complete remission in metastatic melanoma and selected other cancers.

The Pezcoller Foundation-AACR International Award for Extraordinary Achievement in Cancer Research was established in 1997 to annually recognize a scientist who has made a major scientific discovery in basic or translational cancer research. The awardee must be active in cancer research, have a record of recent noteworthy publications, and be conducting ongoing work that holds promise for continued substantive contributions to progress in the field of cancer.

To learn more, please visit the press release.

View Past Recipients

View Dr. Rosenberg’s Fellows of the AACR Academy page